Wierbiłowicz, Krzysztof https://orcid.org/0000-0002-6896-7846
Yang, Chun-Song https://orcid.org/0009-0002-9770-5594
Almaghasilah, Ahmed https://orcid.org/0009-0002-1234-206X
Wesołowski, Patryk A https://orcid.org/0000-0002-7751-980X
Pracht, Philipp
Dworak, Natalia M
Masur, Jack https://orcid.org/0009-0008-5853-9697
Wijngaarden, Sven
Filippov, Dmitri V
Wales, David J
Kelley, Joshua B https://orcid.org/0000-0002-5700-1173
Ratan, Aakrosh https://orcid.org/0000-0002-0782-3056
Paschal, Bryce M https://orcid.org/0000-0001-8593-0503
Funding for this research was provided by:
HHS | NIH | National Cancer Institute (R01CA214872)
HHS | NIH | National Cancer Institute (R01CA178393)
HHS | NIH | National Institute of General Medical Sciences (R15GM140409)
Saunders Memorial Funding, UVA Comprehensive Cancer Center
Alexander von Humboldt Foundation for a Feodor Lynen Research Fellowship
Engineering and Physical Sciences Research Council (EPSRC) studentship through Doctoral Training Partnership (EP/W524633/1)
Article History
Received: 8 January 2025
Revised: 30 June 2025
Accepted: 2 July 2025
First Online: 18 July 2025
Disclosure and competing interests statement
: The authors declare no competing interests. BMP discloses that he is a co-founder of Define Therapeutics.